Prediction of human pharmacokinetics based on preclinical in vitro and in vivo data

被引:0
|
作者
Lavé, T [1 ]
Luttringer, O [1 ]
Zuegge, J [1 ]
Schneider, G [1 ]
Coassolo, R [1 ]
Theil, FR [1 ]
机构
[1] F Hoffmann La Roche Inc, Drug Discovery Support, CH-4070 Basel, Switzerland
关键词
D O I
暂无
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
引用
收藏
页码:81 / 104
页数:24
相关论文
共 50 条
  • [41] Pharmacokinetics in vivo and in vitro in swine
    Witkamp, RF
    Monshouwer, M
    SCANDINAVIAN JOURNAL OF LABORATORY ANIMAL SCIENCE, 1998, 25 : 45 - 56
  • [42] Prediction of human fetal pharmacokinetics using ex vivo human placenta perfusion studies and physiologically based models
    Mendes, Mailys De Sousa
    Hirt, Deborah
    Vinot, Cecile
    Valade, Elodie
    Lui, Gabrielle
    Pressiat, Claire
    Bouazza, Naim
    Foissac, Frantz
    Blanche, Stephane
    Le, Minh Patrick
    Peytavin, Gilles
    Treluyer, Jean-Marc
    Urien, Saik
    Benaboud, Sihem
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2016, 81 (04) : 646 - 657
  • [43] Methods for Predicting In Vivo Pharmacokinetics Using Data from In Vitro Assays
    Houston, J. Brian
    Galetin, Aleksandra
    CURRENT DRUG METABOLISM, 2008, 9 (09) : 940 - 951
  • [44] Human serum butyrylcholinesterase: In vitro and in vivo stability, pharmacokinetics, and safety in mice
    Saxena, A
    Sun, W
    Luo, CY
    Doctor, BP
    CHEMICO-BIOLOGICAL INTERACTIONS, 2005, 157 : 199 - 203
  • [45] Prediction of Human Pharmacokinetics from Preclinical Information of Rhein, an Antidiabetic Nephropathy Drug, Using a Physiologically Based Pharmacokinetic Model
    Hao, Kun
    Qi, Qu
    Wan, Ping
    Zhang, Jingwen
    Hao, Haiping
    Liang, Yan
    Xie, Lin
    Wang, Guangji
    Sun, Jianguo
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2014, 114 (02) : 160 - 167
  • [46] Preclinical Pharmacokinetics of MI-219, a Novel Human Double Minute 2 (HDM2) Inhibitor and Prediction of Human Pharmacokinetics
    Zou, Peng
    Zheng, Nan
    Yu, Yanke
    Yu, Shanghai
    Sun, Wei
    McEachern, Donna
    Yang, Yongsheng
    Yu, Lawrence X.
    Wang, Shaomeng
    Sun, Duxin
    JOURNAL OF PHARMACY AND PHARMACEUTICAL SCIENCES, 2012, 15 (02): : 265 - 280
  • [47] Prediction of pharmacokinetic profile of valsartan in human based on in vitro uptake transport data
    Agnès Poirier
    Anne-Christine Cascais
    Christoph Funk
    Thierry Lavé
    Journal of Pharmacokinetics and Pharmacodynamics, 2009, 36 : 585 - 611
  • [48] Prediction of pharmacokinetic profile of valsartan in human based on in vitro uptake transport data
    Poirier, Agnes
    Cascais, Anne-Christine
    Funk, Christoph
    Lave, Thierry
    JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS, 2009, 36 (06) : 585 - 611
  • [49] Preclinical pharmacokinetics and disposition of a novel selective VEGFR inhibitor Fruquintinib (HMPL-013) and the prediction of its human pharmacokinetics
    Yi Gu
    Jian Wang
    Ke Li
    Li Zhang
    Hongcan Ren
    Lixia Guo
    Yang Sai
    Weihan Zhang
    Weiguo Su
    Cancer Chemotherapy and Pharmacology, 2014, 74 : 95 - 115
  • [50] Preclinical pharmacokinetics and disposition of a novel selective VEGFR inhibitor Fruquintinib (HMPL-013) and the prediction of its human pharmacokinetics
    Gu, Yi
    Wang, Jian
    Li, Ke
    Zhang, Li
    Ren, Hongcan
    Guo, Lixia
    Sai, Yang
    Zhang, Weihan
    Su, Weiguo
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2014, 74 (01) : 95 - 115